Drug discovery by single crystal X-ray structure analysis
In the early stages of new drug discovery, the structure of small molecule hits resulting from compound screening is modified to derive leads (putative drug...
In the early stages of new drug discovery, the structure of small molecule hits resulting from compound screening is modified to derive leads (putative drug...
XtaLAB mini is a benchtop small molecule X-ray crystallography system. This chemical crystallography system is designed to produce publication quality structures automatically even though it...
MILabs B.V. (Headquarters: The Netherlands, hereinafter MILabs), which joined the Rigaku Group in August 2021, is a leading global manufacturer of preclinical imaging systems. Preclinical...
Among the various analysis techniques, single crystal X-ray structure analysis can be regarded as the most effective analysis technique for acquiring knowledge about the 3-dimensional...
Riding on the success of the XtaLAB mini as a compact, low-maintenance, benchtop system providing high-quality crystal structures, the new XtaLAB mini II has been developed. The...